Item 1. | Security and Issuer |
(a) | Title of Class of Securities:
Common Stock, par value $0.0001 per share |
(b) | Name of Issuer:
Aeva Technologies, Inc. |
(c) | Address of Issuer's Principal Executive Offices:
555 Ellis Street, Mountain View,
CALIFORNIA
, 94043. |
Item 2. | Identity and Background |
|
(a) | Soroush Salehian Dardashti |
(b) | The business address of the Reporting Person is c/o Aeva Technologies, Inc., 555 Ellis Street, Mountain View, CA 94043 |
(c) | The Reporting Person's present principal occupation is Chief Executive Officer of the Issuer. |
(d) | During the last five years, the Reporting Person has not been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors). |
(e) | The Reporting Person is not, nor during the last five years has been, a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
(f) | The Reporting Person is a citizen of the United States. |
Item 3. | Source and Amount of Funds or Other Consideration |
| See Item 5 below. |
Item 4. | Purpose of Transaction |
| Except as described herein, neither the Reporting Person nor any affiliated trusts or entities has any present plans or proposals that relate to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. However, the Reporting Person and the Trust reserve the right to formulate in the future plans or proposals which may relate to or result in the transactions described in subparagraphs (a) through (j) of this Item 4.
The Reporting Person and the Trust hold the securities of the Issuer for general investment purposes. The Reporting Person, and the Trust reserve the right, based on all relevant factors and subject to applicable law or other restrictions, at any time and from time to time, to acquire additional shares of Common Stock or other securities of the Issuer, dispose of some or all of the shares of Common Stock or other securities of the Issuer that it may own from time to time, in each case in open market or private transactions, block sales or otherwise or pursuant to ordinary stock exchange transactions effected through one or more broker-dealers whether individually or utilizing specific pricing or other instructions (including by means of Rule 10b5-1 trading plans). |
Item 5. | Interest in Securities of the Issuer |
(a) | See Items 7-11 and 13 of the cover pages of this Statement for the Reporting Person and Item 2 above. |
(b) | See Items 7-11 and 13 of the cover pages of this Statement for the Reporting Person and Item 2 above. |
(c) | Following is a description of the transactions in securities of the Issuer by the Reporting Person since the sixtieth day prior to the date of the event requiring the filing of this Statement: On September 3, 2024, pursuant to a previously adopted Rule 10b5-1 trading plan, the Trust sold 85,601 shares of Common Stock at a weighted-average price of $2.8435 for aggregate sale proceeds of $243,406.44. On September 4, 2024, pursuant to a previously adopted Rule 10b5-1 trading plan, the Trust sold 124,721 shares of Common Stock at a weighted-average price of $2.5772 for aggregate sale proceeds of $321,430.96. On September 5, 2024, pursuant to a previously adopted Rule 10b5-1 trading plan, the Trust sold 49,678 shares of Common Stock at a weighted-average price of $2.5458 for aggregate sale proceeds of $126,470.25. On November 4, 2024, 38,603 shares of Common Stock were withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement upon vesting of restricted stock units held by the Reporting Person. On December 2, 2024, pursuant to a previously adopted Rule 10b5-1 trading plan, the Trust sold 107,795 shares of Common Stock at a weighted-average price of $4.4945 for aggregate sale proceeds of $484,484.63. On December 3, 2024, pursuant to a previously adopted Rule 10b5-1 trading plan, the Trust sold 132,205 shares of Common Stock at a weighted-average price of $4.3497 for aggregate sale proceeds of $575,052.09. |
(d) | Except as reported in this Statement, no other person is known to the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement. |
(e) | Not applicable. |
Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
| Not applicable |
Item 7. | Material to be Filed as Exhibits. |
| Not applicable |